The Nelson's syndrome... revisited

Author： Assié Guillaume   Bahurel Hélène   Bertherat Jérôme   Kujas Michèle   Legmann Paul   Bertagna Xavier  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.7, Iss.4, 2004-12, pp. : 209-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and biochemical stabilization of Nelson’s syndrome with long-term low-dose cabergoline treatment

By Shraga-Slutzky Ilana   Shimon Ilan   Weinshtein Ruth  

Pituitary, Vol. 9, Iss. 2, 2006-06 ,pp. : 151-154

Springer Publishing Company

Access to resources Recommend Favorite

Low Immunohistochemical Expression of MGMT in ACTH Secreting Pituitary Tumors of Patients with Nelson Syndrome

By Salehi Fateme  

Endocrine Pathology, Vol. 21, Iss. 4, 2010-12 ,pp. : 227-229

Humana Press, Inc

Access to resources Recommend Favorite

Possible role of a radiation-induced p53 mutation in a Nelson's syndrome patient with a fatal outcome

By Pinto Emilia  

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 400-404

Springer Publishing Company

Access to resources Recommend Favorite

Measurement of Prethrombotic Markers in the Assessment of Acquired Hypercoagulable States - Trousseau's syndrome revisited

By Lopez Y.   Paloma M.J.   Rifon J.   Cuesta B.   Paramo J.A.  

Thrombosis Research, Vol. 93, Iss. 2, 1999-01 ,pp. : 71-78

Elsevier

Access to resources Recommend Favorite

Markers of Activated Hemostasis and Fibrinolysis in Patients with Pulmonary Malignancies - Trousseau's syndrome revisited

By Kalweit G.A.   Feindt P.   Micek M.   Gams E.   Hellstern P.  

Thrombosis Research, Vol. 97, Iss. 3, 2000-02 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite